Search Results - "Amon, Luis Carlos"

SAMe-TT2R2 Score in the Outpatient Anticoagulation Clinic to Predict Time in Therapeutic Range and Adverse Events by Pivatto Junior, Fernando, Scheffel, Rafael Selbach, Ries, Lucas, Wolkind, Ricardo Roitman, Marobin, Roberta, Barkan, Sabrina Sigal, Amon, Luís Carlos, Biolo, Andréia

“…The SAMe-TT2R2 score was developed to predict which patients on oral anticoagulation with vitamin K antagonists (VKAs) will reach an adequate time in…”
Get full text

Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry by Botton, Mariana Rodrigues, Bandinelli, Eliane, Rohde, Luis Eduardo Paim, Amon, Luis Carlos, Hutz, Mara Helena

“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Warfarin is an oral anticoagulant widely used for thromboembolic disease prophylaxis. The pharmacokinetics and…”
Get full text

Major bleeding risk assessment in atrial fibrillation patients taking vitamin K antagonists by Pivatto, Fernando, Silva, André Luís Ferreira da, Bezerra, Indira Valente, Pires, Leonardo Martins, Amon, Luís Carlos, Blaya, Marina Bergamini, Scheffel, Rafael Selbach

“…Background. The use of risk scores for the assessment of major bleeding and stroke in patients with atrial fibrillation (AF) helps evaluate the risks and…”
Get full text

SAMe-TT2R2 Score: A Useful Tool in Oral Anticoagulation Decision-Making for Venous Thromboembolism Patients? by Pivatto Júnior, Fernando, Salla, Rafaela Fenalti, Cé, Lísia Cunha, Biolo, Andréia, Silva, André Luís Ferreira Azeredo da, Führ, Bruno, Amon, Luís Carlos, Blaya, Marina Bergamini, Scheffel, Rafael Selbach

“…Abstract Background: The SAMe-TT2R2 score was introduced to identify atrial fibrillation patients with a high risk of not achieving a good time in therapeutic…”
Get full text

Use of HAS-BLED Score in an Anticoagulation Outpatient Clinic of a Tertiary Hospital by Beltrame, Rafael Coimbra Ferreira, Giasson, Franciele Taís Bandeira, Silva, André Luís Ferreira Azeredo da, Gomes, Bruna Sessim, Amon, Luís Carlos, Blaya, Marina Bergamini, Scheffel, Rafael Selbach, Pivatto Júnior, Fernando

“…Abstract Background: HAS-BLED score was developed to assess 1-year major bleeding risk in patients anticoagulated with vitamin K antagonists (VKA) due to…”
Get full text

Major bleeding risk assessment in atrial fibrillation patients taking vitamin K antagonists by Fernando Pivatto Júnior, André Luís Ferreira da Silva, Indira Valente Bezerra, Leonardo Martins Pires, Luís Carlos Amon, Marina Bergamini Blaya, Rafael Selbach Scheffel

“…Background. The use of risk scores for the assessment of major bleeding and stroke in patients with atrial fibrillation (AF) helps evaluate the risks and…”
Get full text

Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic by Fernando Pivatto Júnior, André Luis Ferreira da Silva, Bárbara Bárbara Marina Simionato, Fernanda Fuzinatto, Jerônimo De Conto Oliveira, Leonardo Martins Pires, Roberta Cristina Petry, Rafael Selbach Scheffel, Luís Carlos Amon

“…Introduction: atrial fibrillation (AF) is one of the main risk factors for stroke. Vitamin K antagonists (VKA) reduce this risk, and the effectiveness of this…”
Get full text

Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic by Fernando Pivatto Júnior, André Luis Ferreira da Silva, Bárbara Bárbara Marina Simionato, Fernanda Fuzinatto, Jerônimo De Conto Oliveira, Leonardo Martins Pires, Roberta Cristina Petry, Rafael Selbach Scheffel, Luís Carlos Amon

“…Introduction: atrial fibrillation (AF) is one of the main risk factors for stroke. Vitamin K antagonists (VKA) reduce this risk, and the effectiveness of this…”
Get full text